Universal Beteiligungs und Servicegesellschaft mbH Sells 42,142 Shares of Revvity Inc. $RVTY

Universal Beteiligungs und Servicegesellschaft mbH reduced its stake in shares of Revvity Inc. (NYSE:RVTY) by 46.4% in the fourth quarter, HoldingsChannel reports. The firm owned 48,769 shares of the company’s stock after selling 42,142 shares during the period. Universal Beteiligungs und Servicegesellschaft mbH’s holdings in Revvity were worth $4,745,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of RVTY. Byrne Asset Management LLC increased its position in shares of Revvity by 0.9% during the fourth quarter. Byrne Asset Management LLC now owns 11,138 shares of the company’s stock worth $1,078,000 after purchasing an additional 100 shares in the last quarter. Trust Point Inc. boosted its position in shares of Revvity by 3.8% in the 4th quarter. Trust Point Inc. now owns 3,215 shares of the company’s stock worth $311,000 after purchasing an additional 117 shares in the last quarter. First National Advisers LLC grew its stake in Revvity by 0.8% during the 3rd quarter. First National Advisers LLC now owns 15,023 shares of the company’s stock worth $1,317,000 after buying an additional 125 shares during the last quarter. Farther Finance Advisors LLC grew its stake in Revvity by 26.2% during the 4th quarter. Farther Finance Advisors LLC now owns 698 shares of the company’s stock worth $68,000 after buying an additional 145 shares during the last quarter. Finally, Mackenzie Financial Corp increased its position in Revvity by 1.7% during the 3rd quarter. Mackenzie Financial Corp now owns 8,955 shares of the company’s stock valued at $785,000 after buying an additional 154 shares in the last quarter. 86.65% of the stock is currently owned by institutional investors and hedge funds.

Revvity Trading Down 1.8%

Shares of NYSE:RVTY opened at $85.23 on Wednesday. Revvity Inc. has a 12-month low of $81.36 and a 12-month high of $118.30. The company has a market capitalization of $9.53 billion, a PE ratio of 40.98, a PEG ratio of 1.85 and a beta of 1.13. The business has a 50 day moving average of $90.96 and a two-hundred day moving average of $96.91. The company has a current ratio of 1.68, a quick ratio of 1.40 and a debt-to-equity ratio of 0.36.

Revvity (NYSE:RVTY) last issued its quarterly earnings data on Monday, February 2nd. The company reported $1.70 EPS for the quarter, topping analysts’ consensus estimates of $1.55 by $0.15. The business had revenue of $772.06 million for the quarter, compared to analysts’ expectations of $759.81 million. Revvity had a net margin of 8.45% and a return on equity of 7.92%. The business’s revenue was up 5.9% on a year-over-year basis. During the same quarter last year, the company earned $1.42 EPS. Revvity has set its FY 2026 guidance at 5.350-5.450 EPS. As a group, analysts forecast that Revvity Inc. will post 5.39 EPS for the current year.

Analyst Ratings Changes

RVTY has been the subject of a number of research analyst reports. Barclays reiterated an “equal weight” rating and issued a $95.00 price target (down from $118.00) on shares of Revvity in a research note on Tuesday, April 14th. Robert W. Baird set a $129.00 price objective on shares of Revvity in a report on Tuesday, February 3rd. Jefferies Financial Group increased their price objective on shares of Revvity from $100.00 to $105.00 and gave the company a “hold” rating in a research report on Monday, February 2nd. The Goldman Sachs Group lowered their target price on shares of Revvity from $110.00 to $95.00 and set a “neutral” rating for the company in a research note on Tuesday, April 14th. Finally, Wells Fargo & Company boosted their target price on shares of Revvity from $107.00 to $110.00 and gave the stock an “equal weight” rating in a research report on Tuesday, February 3rd. Four research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $110.17.

About Revvity

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.